SCHEMBL27484537

SCHEMBL27484537

N#Cc1cccc(NC(=O)c2cccc(N)c2Cc2ccncc2)c1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.53
▸ EGLN1 Q9GZT9 1/20 0.49
▸ GRM4 Q14833 1/20 0.49
▸ ROCK2 O75116 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.47
▸ SGMS2 Q8NHU3 1/20 0.47
▸ BLM P54132 1/20 0.47
▸ P2RX1 P51575 1/20 0.47
▸ ATR Q13535 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.45
▸ GRM5 P41594 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45
▸ GCK P35557 1/20 0.44
▸ BRAF P15056 1/20 0.44
▸ NR1H4 Q96RI1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27468045 0.84 KDR (0.44) HTTALDH1A1LMNA
SCHEMBL27486254 0.84 SMN1; SMN2 (0.53) HTTALDH1A1LMNA
SCHEMBL27485938 0.84 PRKCI (0.53) LMNA
SCHEMBL27484538 0.84 CYP17A1 (0.56) HTTALDH1A1ATRLMNA
SCHEMBL27465575 0.84 P2RX1 (0.50) HTTALDH1A1P2RX1GRM5LMNA
SCHEMBL27548625 0.84 KDR (0.59) GRM4ALDH1A1P2RX1
SCHEMBL27508410 0.83 KCNK3 (0.45) ALDH1A1ATRLMNA
SCHEMBL27466657 0.81 PTGS1 (0.64) P2RX1RXFP1
SCHEMBL27519714 0.81 MEN1 (0.51) ALDH1A1ATRLMNABRAF
SCHEMBL27485596 0.81 KCNK3 (0.49) HTTALDH1A1BLMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN claimed
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN disclosed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN disclosed
Send feedback